Therapeutic Embolization and Vessel Occlusion to Treat Pelvic Conditions
Customize your policy alerts
Sign up for healthspring Policy SUR701.015 alerts
Get alerted when Policy SUR701.015 changes without checking for updates manually.
Monitor payer policy activity
This policy governs when transcatheter therapeutic embolization or vessel occlusion may be considered medically necessary for selected pelvic conditions, including uterine fibroids, postpartum hemorrhage, symptomatic varicocele, and pelvic congestion syndrome. Coverage is subject to stated clinical criteria and documentation, the member’s benefit plan, and applicable state requirements.
A new medical policy was issued stating that transcatheter therapeutic embolization or vessel occlusion may be medically necessary when the Coverage criteria are met.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.